Physician profile
Dae Kim
NPI 1003000597
$11,396.93
in general payments reported to CMS, 2019-2025
36 companies · $1,880 in 2025
The $1,880 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,316 · 2020: $831 · 2021: $395 · 2022: $1,857 · 2023: $1,833 · 2024: $2,286 · 2025: $1,880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,830 · Travel and Lodging: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,829.77 |
| Travel and Lodging | $1,168.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,571.16 | 2020-2024 | Axonics, Bulkamid |
| Neotract INC. | $1,430.33 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $1,239.21 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $1,148.77 | 2019-2025 | Axonics, Spaceoar System, Ams 700 |
| Teleflex LLC | $927.22 | 2021-2025 | Barrigel, Urolift |
| Procept Biorobotics Corporation | $718.77 | 2022-2023 | Aquabeam Robotic System |
| Abbvie INC. | $443.82 | 2019-2025 | |
| Urovant Sciences INC | $425.98 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $390.05 | 2022-2024 | Myrisk, Prolaris |
| Astellas Pharma US INC | $389.33 | 2019-2022 | |
| Pfizer INC. | $384.56 | 2019-2025 | |
| Medtronic, INC. | $331.21 | 2022-2025 | Altaviva, Interstim |
| Stryker Corporation | $296.52 | 2023-2025 | 1788, 1688 |
| Coloplast Corp | $294.27 | 2019-2024 | Titan, Speedicath |
| Olympus America INC. | $166.46 | 2023-2025 | Itind System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $141.78 | 2024 | Xiaflex |
| Janssen Biotech, INC. | $127.35 | 2022-2023 | Erleada |
| Myovant Sciences INC. | $118.74 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $115.33 | 2019-2020 | |
| Urogen Pharma, INC. | $114.12 | 2022-2025 | Jelmyto |
| Calyxo, INC. | $108.23 | 2025 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $78.12 | 2023-2024 | Xiaflex, Aveed |
| Therapeuticsmd, INC. | $67.32 | 2019-2022 | |
| Civco Medical Instruments | $55.25 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $51.20 | 2024-2025 | |
| Medtronic USA, INC. | $41.50 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $34.35 | 2023 | Seglentis |
| Intuitive Surgical, INC. | $31.10 | 2025 | |
| Accord Healthcare, INC. | $31.06 | 2024-2025 | |
| Allergan, INC. | $22.25 | 2019 | |
| Ambu INC. | $22.19 | 2024 | |
| Laborie Medical Technologies Corp. | $20.51 | 2025 | |
| Amgen INC. | $18.42 | 2019 | |
| Dendreon Pharmaceuticals LLC | $14.02 | 2025 | Provenge |
| Cook Medical LLC | $13.59 | 2019 | |
| Kci USA, INC. | $12.84 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dae Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.